(MAPS JAPAC President) / Vice President and Region Head Medical, JAPAC / Amgen | ビクトリア・エレガント VP 地域メディカルアフェアーズ アムジェン
Professor Victoria Elegant joined Amgen in October 2016 and is Vice-President, JAPAC Regional Medical Head, based in Hong Kong.
Professor Elegant is a physician who joined the pharmaceutical industry after postgraduate training in obstetrics and gynecology in the UK. She has held positions in global drug development, medical affairs, regulatory affairs and drug safety in Japan, Australia, Europe and Asia Pacific. Prior to Amgen, Dr. Elegant was the Vice-President, Regulatory and Medical Affairs, APAC, based in Shanghai for Baxter, and Vice President, Medical Affairs, Asia/ANZ for Baxalta.
Professor Elegant is actively engaged in the training and education of physicians in the healthcare industry. She was involved with establishing the first postgraduate training course for pharmaceutical physicians in Australia. Dr. Elegant is a Fellow of the Faculty of Pharmaceutical Medicine, a member of the FPM International Committee, and is currently working on training programs in the Asia-Pacific region. She is on the Board of Studies for the Masters in Pharmaceutical Medicine, UNSW. She is a founding member of the China Medical Affairs Network. She is on the board of the Medical Affairs Professional Society, and is Adjunct Professor, Faculty of Medicine, University of New South Wales, Sydney Australia
Professor Elegant is passionate about promoting diversity and inclusion, especially in supporting women and leadership. She was involved in Building Talent Edge, a Catalyst Award-winning program supporting women in Baxter Healthcare and leading to a 50:50 men:women ratio at the senior manager level and above across the Asia-Pacific region.
Jan van Overbeeke, M.Sc., MBA, based in Tokyo, co-leads Medical Affairs for McKinsey across Asia. As part of his work, he provides leadership in client service on medical topics across the Asia region, publishes in the public domain, oversees McKinsey’s Medical Affairs Performance Evaluation Survey and hosts Medical Affairs leadership round-tables. Mr. van Overbeeke started with McKinsey in the Netherlands, and since then has served pharmaceutical and medical device companies across Europe, the US and Asia during his 3 year tenure in the United Kingdom and since 2014 in Japan. A native of the Netherlands, Mr. van Overbeeke received his Engineering degree from the Technical University of Delft and his law degree from the University of Leiden. He completed a full-time MBA program at INSEAD in Singapore and France.
(MAPS President) / EVP and Head of Medical Affairs / Astellas Pharma
Charlotte M. E. Kremer, MD, MBA is the Executive VP and head of Medical Affairs for Astellas. In this role, Dr. Kremer provides leadership for the Medical Affairs organization globally.
Dr. Kremer joined Astellas in 2012 with 20 years of experience in the pharmaceutical industry. Prior to Astellas, she held the position of Vice President, Therapeutic Area Head for Ophthalmology, PVD, Rare Diseases and Neuroscience at Pfizer. While at Pfizer, she successfully led and executed the clinical development and global medical programs in these respective areas. Prior to joining Pfizer, Dr. Kremer held positions of increasing responsibility providing medical support, developing Phase 3b/4 clinical trials, and initiating and directing a Medical Liaison program at Organon Pharmaceuticals, both in the Netherlands and in the United States. A native of the Netherlands, Dr. Kremer received her medical degree from the University of Utrecht, The Netherlands. She went on to receive her Diploma Pharmaceutical Medicine (DPM) from Universite Libre de Bruxelles. After transferring to the United States, Dr. Kremer completed the Executive MBA program at New York University’s Leonard N. Stern School of Business.
Regional Medical Head / JPAC Japan / Sanofi Japan | クライン マーカス JPACリージョナル メディカル ヘッド サノフィ株式会社
Dr. Marcus Klein is a Senior Director and Medical Head of JPAC (Japan, South Korea and Australia/NZ) with Sanofi Genzyme, based in Tokyo. He oversees the Medical Affairs function for the JPAC Region. Dr. Klein has more than 25 years of experience in R&D and Medical Affairs. He held different senior positions in R&D and MA based in Germany, the UK, Singapore and Japan with Schering AG, Bayer Pharmaceuticals, Invida, Merck Serono, and Sanofi Genzyme.
Dr. Klein is a MD and holds a PhD from the Free University, Berlin. He has attended leadership programs at Duke University (USA) and London Business School.
Corporate Executive, SVP and Head of Medical Affairs, Japan / Astellas Pharma Inc / Japan
Mr. Takuya Oshida is currently Corporate Executive, SVP and Head of Medical Affairs, Japan at Astellas Pharma Inc. In this role, he is responsible for leading the regional Medical Affairs functions which include Medical Science, Medical Science Liaison and Medical Communications in Japan. Mr. Oshida has more than 25 years of pharmaceutical industry experiences. Prior to the current position, he had engaged in clinical development and experienced the successful launches of several products, including tacrolimus, enzalutamide and linaclotide.
Mr. Oshida received Master of Science degree in Pharmaceutical Sciences from Osaka University and he is a Registered Pharmacist in Japan.
Operating Officer, Head of Medical Affairs / BAYER YAKUHIN | 犬山 里代 執行役員 メディカルアフェアーズ本部長 バイエル薬品株式会社
1. Graduated from Tokyo Women’s Medical University and worked as clinician in Ear, Nose and Throat. (Otolaryngologist)
2. Started a career in pharmaceutical industry in 1997.
3. After working in a few Japan based global pharma companies, hasS been working at Bayer since 2008. 4. Currently Head of Medical Affairs Division at Bayer
Vice President, Japan Medical Officer & Head, Japan Medical Affairs / TAKEDA | ジュベル・フェルナンデス ジャパン ファーマ ビジネス ユニット メディカルアフェアーズ部長 武田薬品工業株式会社
Jovelle graduated from BS Biology and Doctor of Medicine (Saint Louis University, Philippines) and is an Obstetrician Gynecologist with specialty in Reproductive Endocrinology, Infertility and Gynecologic Oncology. She obtained Doctor of Philosophy major in Surgical Sciences and did post-doctoral studies in the field of Molecular Biology and Oncology (Kobe University Graduate School of Medicine, Japan). She was granted permission to practice medicine in Japan under the provision of Article 3, Paragraph 1 of the Japan Law on Exceptions to the Medical Practitioners’ Law, Article 7 on the Advanced Clinical Training of Foreign Medical Practitioners. She also obtained various business certifications and executive education programs from Harvard School of Medicine, University of Pennsylvania Wharton School of Business, INSEAD, Rotterdam School of Management and Oxford Said Business School.
She was awarded the best poster presentation by the Japan Society of Obstetrics and Gynecology in 1999, and in 2005, obtained the best oral presenter award and Young Gynecologist Award from the Asia Oceania Federation of Obstetrics and Gynecology. She has published over 30 studies in peer-reviewed journals and has made over 100 oral presentations/chaired scientific sessions in Asia Pacific including Japan, Europe and US.
She has worked for more than 12 years in the pharmaceutical industry. Prior to joining Takeda Pharmaceuticals in November 2015, she worked at GlaxoSmithKline (GSK) of increasing leadership in various territories – regional medical affairs (Asia Pacific, Australasia, China/Hong Kong, Japan), global medical affairs and North America Medical Affairs (US and Canada).
In Takeda, she heads the Japan Medical Affairs organization involving physicians, allied health care providers and those with advanced science degrees and her team is responsible for scientific exchange and evidence generation.
She is very much involved with various charity activities (medical missions and feeding programs for under privileged).